|
Aug 8
|
Is Johnson & Johnson Stock a Buy Now?
|
|
Aug 7
|
Johnson & Johnson Plans Exchange Offer for Kenvue
|
|
Aug 7
|
Dow Jones Today: Index Rebounds with 400-Point Gain
|
|
Aug 7
|
Is Johnson & Johnson (NYSE:JNJ) A Risky Investment?
|
|
Aug 6
|
25 Most Health-Conscious States in the US
|
|
Aug 4
|
Bruker (BRKR) Q2 Earnings and Revenues Top, '23 Sales View Up
|
|
Aug 4
|
Better Buy: Johnson & Johnson vs. Proctor & Gamble
|
|
Aug 4
|
The Zacks Analyst Blog Highlights Johnson & Johnson, General Dynamics, Pioneer Natural Resources, Alibaba Group and Autodesk
|
|
Aug 4
|
Itching for a Good Trade? Johnson & Johnson Spinoff Kenvue Should Offer Relief
|
|
Aug 3
|
Buckle Up! 3 Blue-Chip Stocks Set to Soar to New Heights.
|
|
Jul 19
|
12 Highest Yielding Dow Jones Dividend Stocks
|
|
Jul 19
|
American Airlines, Travelers, Johnson & Johnson, housing data: What To Watch
|
|
Jul 19
|
20 Countries with Highest Rates of Infant Mortality
|
|
Jul 19
|
Microsoft-Activision Adjust Deal Deadline Terms, Goldman Sachs' Q2 Profits Fall 60%, Johnson & Johnson Joins Legal Battle Against US Government On Drug Pricing Negotiation: Today's Top Stories
|
|
Jul 19
|
Johnson & Johnson’s Talc Worries Rear as Company Prepares for Earnings
|
|
Jul 19
|
Drug Pricing Negotiation Program: Johnson & Johnson Joins Legal Battle Against US Government
|
|
Jul 19
|
Midday movers: Goldman Sachs, Carvana, Joby Aviation and more
|
|
Jul 19
|
3 No-Brainer Stocks to Buy With $400 Right Now
|
|
Jul 18
|
UPDATE 2-J&J must pay $18.8 mln to California cancer patient in baby powder suit
|
|
Jul 18
|
J&J must pay $18.8 million to California cancer patient in baby powder suit
|